Laboratory Technician
Genvax Technologies
Laboratory Technician
Genvax Technologies
Develops mRNA nanoparticle vaccines for animals
Genvax Technologies · Ames, United States · Full-time · Posted 2026-10-22
Salary: USD 50,000–60,000
Workplace: on_site
We are seeking a highly motivated Technician who thrives in a dynamic environment, demonstrating flexibility, adaptability, and comfort navigating ambiguity while proactively solving problems and adjusting priorities as business needs evolve. This position is primarily responsible for RNA antigen manufacturing and downstream lipid nanoparticle encapsulation as well as testing associated with quality, sterility, reproducibility and safety. The successful candidate will have experience in aseptic techniques, working with RNA and DNA, vaccine formulation and manufacturing, and an understanding of Laboratory Information Management Systems (LIMS) or a willingness to learn. A successful candidate for this role must demonstrate adaptability in dynamic environments, effectively shifting priorities and approaches as project needs evolve, apply critical thinking to troubleshoot both scientific, mechanical and/or engineering challenges, and exercise sound judgment and confidence in making timely, data-informed decisions as well as willingness to step up into responsibilities outside of the job description. This role will support the development and optimization of vaccine candidates, working in a collaborative environment to advance products from research through regulatory approval, scale-up and regulated manufacturing of vaccine production.
Aseptic Technique & Laboratory Work:
Perform cell culture, bacterial culture, and molecular biology techniques under aseptic conditions.
Conduct microbial and sterility testing to ensure contamination-free processes.
RNA and DNA Research & Development:
Extract, purify, and analyze RNA and DNA for vaccine applications.
Develop and optimize nucleic acid-based formulations for vaccine candidates.
Vaccine Formulation & Manufacturing:
Assist in formulation development for nucleic acid vaccines.
Characterize vaccine stability, potency, and immunogenicity utilizing validated assays or designing novel methods to assess.
Laboratory Information Management Systems (LIMS) and Electronic Lab Notebook (ELN):
Record, manage, and analyze experimental data using LIMS and ELN.
Ability to learn and adapt to new LIMS and ELN platforms as required.
Quality & Compliance:
Follow USDA-CVB approved manufacturing and laboratory quality procedures, Good Laboratory Practices, and biosafety guidelines in vaccine production.
Powered by Workable
Develops mRNA nanoparticle vaccines for animals
Genvax Technologies develops mRNA nanoparticle vaccines for animals to prevent and treat veterinary diseases, serving livestock producers, clinics, and animal health organizations. Its vaccines use an mRNA platform packaged in nanoparticles to trigger an immune response, with products advanced through R&D and then sold commercially. The company differentiates itself with a founder-led team tied to a proven track record in animal vaccines and a rapid-response approach to new animal health challenges. Its goal is to improve global animal health by quickly bringing effective animal vaccines to market.
Explore more opportunities at Genvax Technologies